Literature DB >> 17442526

Magnetic resonance angiographic demonstration of carotid-cavernous fistula using elliptical centric time resolved imaging of contrast kinetics (EC-TRICKS).

Surjith Vattoth1, Jigimon Cherian, Tarun Pandey.   

Abstract

Magnetic resonance angiographic evaluation of the intracranial vasculature has been predominantly carried out using conventional angiographic techniques such as time of flight and phase contrast sequences. These techniques have good spatial resolution but lack temporal resolution. Newer faster angiographic techniques have been developed to circumvent this limitation. Elliptical centric time-resolved imaging of contrast kinetics (EC-TRICKS) is one such technique which has combined the use of elliptical centric ordering of the k-space with multiphase 3D digital subtraction MR angiogram (MRA) to achieve excellent temporal resolution of the arterial and venous circulations. Its applications have been mainly in the peripheral vasculature. We report the use of this technique in a case of a high-flow, direct carotid-cavernous fistula to demonstrate its potential in intracranial MR angiography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442526     DOI: 10.1016/j.mri.2007.02.009

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  2 in total

1.  Time-resolved MR angiography of the intracranial venous system: an alternative MR venography technique.

Authors:  Hasan Yiğit; Aynur Turan; Elif Ergün; Pınar Koşar; Uğur Koşar
Journal:  Eur Radiol       Date:  2011-11-20       Impact factor: 5.315

2.  Feasibility of Noninvasive Diagnosis and Treatment Planning in a Case Series with Carotid-Cavernous Fistula using High-Resolution Time-Resolved MR-Angiography with Stochastic Trajectories (TWIST) and Extended Parallel Acquisition Technique (ePAT 6) at 3 T.

Authors:  A Seeger; U Kramer; F Bischof; F Schuettauf; F Ebner; S Danz; U Ernemann; T-K Hauser
Journal:  Clin Neuroradiol       Date:  2014-03-06       Impact factor: 3.649

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.